M. David Osselton - Concepedia

Author

M. David Osselton

Also Known As

M D Osselton, M David Osselton, M. D. OSSELTON, M. D. Osselton, M. David Osselton, M.D. Osselton, M.David Osselton, Michael David Osselton, Michael Osselton

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Home Office Bournemouth University Loughborough University Universidade de São Paulo University of Dundee

About

M. David Osselton is an author at Home Office specializing in medicine, pharmacology, and chromatography.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	28	971
2	Health Sciences	5	5	185
3	Natural Sciences	4	4	181
4	Engineering	3	3	71
5	Education	2	2	64

M. David Osselton

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography–tandem mass spectrometry Mark C. Parkin, Sophie C. Turfus, Norman W. Smith, Journal of Chromatography B BiochemistryGas ChromatographyMedicineDrug PurityBioanalysis	2008	107
Collection of analytical data for benzodiazepines and benzophenones M. Japp, Keith Garthwaite, Anne V. Geeson, Journal of Chromatography A Pharmacological StudyMedicineAnalytical DataPharmacologyPharmacokinetics	1988	74
The extraction and analysis of benzodiazepines in tissues by enzymic digestion and high-performance liquid chromatography M. David Osselton, M.D. Hammond, P.J. Twitchett Journal of Pharmacy and Pharmacology	1977	71
Gas-liquid chromatographic retention indices of 296 non-drug substances on SE-30 or OV-1 likely to be encountered in toxicological analyses J.D. Ramsey, Terence D. Lee, M. David Osselton, Journal of Chromatography A Gas ChromatographyMedicineDrug PurityBioanalysisToxicological Analyses	1980	70
Aurovertin B, a metabolite of Calcarisporium arbuscula Lawrence J. Mulheirn, R. BRIAN BEECHEY, David P. Leworthy, Journal of the Chemical Society Chemical Communications Chemical EngineeringM. D. OsseltonBiochemistryPhysicochemical AnalysisAurovertin B	1974	59
CYP2B6 and OPRM1 gene variations predict methadone-related deaths Hannah Bunten, Weijun Liang, Derrick J. Pounder, Addiction Biology PharmacotherapyMolecular PharmacologyMethadone ActionAddiction MedicinePharmacogenomics	2010	59
Citreoviridin, a specific inhibitor of the mitochondiral adenosine triphosphatase P E Linnett, Andrew D. Mitchell, M. David Osselton, Biochemical Journal Cardiovascular PharmacologyPharmacotherapyMitochondrial BiologyRedox BiologyOxidative Stress	1978	53
The Release of Basic Drugs by the Enzymic Digestion of Tissues in Cases of Poisoning M. David Osselton Journal of the Forensic Science Society Pharmacological StudyBiochemistryPharmacologyPoisoningToxicology	1977	49
The United Kingdom and Ireland Association of Forensic Toxicologists Gail Cooper, Sue Paterson, M. David Osselton Science & Justice Forensic MedicineMedical ToxicologyEnvironmental HealthForensic ToxicologyToxicology	2010	47
Increased DNA Methylation of ABCB1 , CYP2D6 , and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers Poppy McLaughlin, Helen Mactier, Cheryl Gillis, The Journal of Pediatrics Newborn InfantsAddictionMedicineDna MethylationGynecology	2017	44

Page 1